BioCrete ApS: Financial statements 2024
CVR: 41353430
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BioCrete ApS (CVR 41353430) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -18,443 and a net result of DKK -26,885 compared with DKK -286,192 the year before. Equity in the 2024 report amounted to DKK 114,960. The solvency ratio was 93.5%.
- Gross Profit
- DKK -18,443
- Profit/Loss
- DKK -26,885
- Equity
- DKK 114,960
- Total Assets
- DKK 122,960
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -18 t. | -27 t. | 115 t. | - |
| 2023 | - | -278 t. | -286 t. | 142 t. | - |
| 2022 | - | 590 t. | -758 t. | 428 t. | - |
| 2021 | - | 1.1 mio. | 1 mio. | 1.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BioCrete ApS has published its annual report for 2023. Gross profit came to DKK -277,750, and the net result was DKK -286,192.
About BioCrete ApS
BioCrete ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lasse Nørbye Døssing. The company's owners include CemGreen ApS, COPAseed A/S and Sean Crowe Holdings Ltd.. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -23,990 and a net result of DKK -33,465 compared with DKK -26,885 the year before. Equity in the 2025 report amounted to DKK 81,495.